HPV Vaccine Creator Ian Frazer Sees Progress in UQ Medical Community
The vision to create an Australian-first home for medical research, clinical trials and treatment commercialisation recently reached an historic milestone with the official start of construction on the $354 million Translational Research Institute (TRI) in Brisbane.
Professor Ian Frazer, director of The University of Queensland Diamantina Institute – as the man behind the cervical cancer vaccine – said the TRI would be home to world-leading researchers focused on translating scientific knowledge into practical benefits for the community.
The TRI would be a key platform in assisting Australian medical scientists to keep greater control of breakthrough drugs such as Professor Frazer’s cervical cancer vaccine, instead of it being necessary for them to sign away the rights to global pharmaceutical companies early in the development process.
Professor Ian Frazer is a creator of the HPV vaccine against cervical cancer; the second cancer preventing vaccine, and the first vaccine designed to prevent a cancer. In 2006, he earned the Australian of the Year award.
OzTREKK has always followed Frazer’s career, as his research and HPV developments progressed as we started our company in 2002, and his work was recognized worldwide following this time. With our connection to Australia, and to the University of Queensland, we applaud Frazer’s continued work in the medical field, and bringing Australia to the forefront of production.
Learn more about the University of Queensland Medical Program.
Find out why so many Canadians enroll at the University of Queensland each year.